American Epilepsy Society Annual Meeting
American Epilepsy Society Annual Meeting
DAY 3
Research Roundup: New Developments in the Understanding of Epilepsy and the Application of Antiepileptic Therapies
Researchers at the American Epilepsy Society meeting reported important strides in the understanding of epilepsy, including identification of new therapeutic targets in the brain, as discussed by Esther Krook-Magnuson, PhD, as well as improved understanding of the factors involved in sudden death of patients with epilepsy, and a greater recognition of the benefits of neurosurgery in patients with epilepsy.
Integrating New Antiepileptic Medications into Clinical Practice: Ezogabine and Eslicarbazepine
Several new antiepileptic drugs have recently been approved in the United States. In a symposium at the American Epilepsy Society in Seattle, Washington, Professor Martin J. Brodie, MD, director of the epilepsy unit of the Western Infirmary in Glasgow, Scotland, discussed some considerations with ezogabine and eslicarbazepine.
Predicting Seizures Before They Happen, Using Novel Sensors, Biomarkers, and Big Data
Mark Cook, MD, of the University of Melbourne, and Brian Litt, MD, of the Penn Epilepsy Center and the Center for Neuroengineering and Therapeutics at the University of Pennsylvania, discuss how new devices, big data, and massive online competitions are enabling prediction of seizures before they start.
DAY 2
From Gene to Animal Model to Treatment: Modeling of Specific Epilepsy Subtypes to Develop More Advanced Treatments
S. L. Moshé, MD, of the Albert Einstein College of Medicine and Montefiore Medical Center, discusses the importance of creating disease-specific models of epilepsy in animal models for understanding and treating specific epilepsy subtypes.
Understanding the Epilepsy Spectrum Through Genes and Linked Diseases May Transform Epilepsy Management
The links between epilepsy and other diseases offer clues for early treatment. Frances E. Jensen, MD, past AES president and professor at Cornell Medical School, describes these links, and what they mean for future epilepsy treatment modalities.
Considering Alternative Treatments for Epilepsy: Ketogenic Diets, Marijuana, and Progesterone
Kristen Park, MD, assistant professor of pediatrics and neurology at the University of Colorado, discussed the potential risks and benefits of alternative therapies for epilepsy, including medical marijuana.
DAY 1
Managing Adverse Events Associated with Acute Treatment of Epilepsy
Treating patients with status epilepticus is a challenging balance of minimizing the risk of medication adverse events while managing the serious dangers of status epilepticus itself.
Understanding Common Adverse Events Associated with Antiepileptic Medications
Antiepileptic medications are a broad category of drugs with many potential adverse events. In this session, Eugen Trinka, MD, MSc, reviews the most common adverse events associated with these therapies.
Guideline-Recommended Treatments for Symptomatic and Generalized Epilepsies
Understanding the recommendations of evidence-based guidelines is an important component of treating patients with therapies backed by the best available evidence.